Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Key Amino Acid Residues Responsible for the Differences in Substrate Specificity of Human UDP-Glucuronosyltransferase (UGT)1A9 and UGT1A8

Ryoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka and Tsuyoshi Yokoi
Drug Metabolism and Disposition January 2009, 37 (1) 41-46; DOI: https://doi.org/10.1124/dmd.108.022913
Ryoichi Fujiwara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miki Nakajima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroyuki Yamanaka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tsuyoshi Yokoi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 37 no. 1 41-46
DOI 
https://doi.org/10.1124/dmd.108.022913
PubMed 
18832479

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received June 16, 2008
  • Accepted September 30, 2008
  • Published online December 23, 2008.

Article Versions

  • Earlier version (October 2, 2008 - 08:37).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Ryoichi Fujiwara,
  2. Miki Nakajima,
  3. Hiroyuki Yamanaka and
  4. Tsuyoshi Yokoi
  1. Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan
  1. Address correspondence to:
    Dr. Tsuyoshi Yokoi, Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakumamachi, Kanazawa 920-1192, Japan. E-mail: tyokoi{at}kenroku.kanazawa-u.ac.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to November 2023

AbstractFullPdf
Aug 20171164
Sep 20170232
Oct 20170166
Nov 20171228
Dec 20170178
Jan 201801410
Feb 20180122
Mar 20180294
Apr 20180360
May 20181286
Jun 20180253
Jul 20180101
Aug 20180163
Sep 20180185
Oct 2018061
Nov 2018080
Dec 2018912
Jan 2019402
Feb 20191902
Mar 20191313
Apr 20191004
May 2019213
Jun 2019706
Jul 2019904
Aug 20191401
Oct 20191712
Nov 20191400
Dec 20191322
Jan 20201332
Feb 20201421
Mar 20201100
May 20209014
Jun 2020600
Jul 20201000
Aug 2020616
Sep 20201202
Oct 20201502
Nov 20201201
Dec 20202122
Jan 20211374
Feb 20211783
Mar 20211737
Apr 20211020
May 2021832
Jun 20211282
Jul 20212010
Aug 2021331
Sep 2021582
Oct 20212434
Nov 20211833
Dec 20212614
Jan 2022722
Feb 20221310
Mar 2022410
Apr 20221980
May 20222531
Jun 20221321
Jul 20222029
Aug 20221233
Sep 20222023
Oct 20221150
Nov 20221458
Dec 2022738
Jan 20231555
Feb 20231723
Mar 2023914
Apr 2023826
May 20231827
Jun 2023320
Jul 20231948
Aug 2023276
Sep 20231010
Oct 2023724
Nov 20231322

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 37 (1)
Drug Metabolism and Disposition
Vol. 37, Issue 1
1 Jan 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Key Amino Acid Residues Responsible for the Differences in Substrate Specificity of Human UDP-Glucuronosyltransferase (UGT)1A9 and UGT1A8
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Key Amino Acid Residues Responsible for the Differences in Substrate Specificity of Human UDP-Glucuronosyltransferase (UGT)1A9 and UGT1A8

Ryoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka and Tsuyoshi Yokoi
Drug Metabolism and Disposition January 1, 2009, 37 (1) 41-46; DOI: https://doi.org/10.1124/dmd.108.022913

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Key Amino Acid Residues Responsible for the Differences in Substrate Specificity of Human UDP-Glucuronosyltransferase (UGT)1A9 and UGT1A8

Ryoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka and Tsuyoshi Yokoi
Drug Metabolism and Disposition January 1, 2009, 37 (1) 41-46; DOI: https://doi.org/10.1124/dmd.108.022913
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cytochrome P450 4F11 in lung cancer
  • SLC49A4-mediated pyrilamine transport
  • Functional Characterization of 29 CYP4F2 Variants
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics